home / stock / bcacw / bcacw quote
Last: | $0.55 |
---|---|
Change Percent: | 120.0% |
Open: | $0.245 |
Close: | $0.25 |
High: | $0.6799 |
Low: | $0.245 |
Volume: | 872,130 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.55 | $0.245 | $0.25 | $0.6799 | $0.245 | 872,130 | 07-29-2022 |
$0.24 | $0.25 | $0.25 | $0.2598 | $0.24 | 18,136 | 07-28-2022 |
$0.2265 | $0.2073 | $0.2073 | $0.23 | $0.2073 | 11,256 | 07-26-2022 |
$0.1975 | $0.2 | $0.1975 | $0.2 | $0.15 | 1,374 | 07-25-2022 |
$0.16 | $0.15 | $0.16 | $0.16 | $0.1435 | 6,256 | 07-19-2022 |
$0.16 | $0.15 | $0.16 | $0.16 | $0.1499 | 19,155 | 07-18-2022 |
$0.1411 | $0.14 | $0.1411 | $0.1497 | $0.14 | 1,026 | 07-15-2022 |
$0.14 | $0.1405 | $0.14 | $0.143 | $0.1311 | 9,665 | 07-14-2022 |
$0.1379 | $0.1311 | $0.1379 | $0.14 | $0.131 | 6,153 | 07-13-2022 |
$0.131 | $0.131 | $0.131 | $0.131 | $0.131 | 301 | 07-12-2022 |
$0.1311 | $0.1311 | $0.1311 | $0.1311 | $0.1311 | 267 | 07-11-2022 |
$0.1442 | $0.13 | $0.1442 | $0.1442 | $0.13 | 24,972 | 07-08-2022 |
$0.1101 | $0.106 | $0.1101 | $0.13 | $0.106 | 18,073 | 07-07-2022 |
$0.1061 | $0.1061 | $0.1061 | $0.1061 | $0.1061 | 750 | 07-06-2022 |
$0.1061 | $0.106101 | $0.1061 | $0.1061 | $0.1061 | 110 | 07-05-2022 |
$0.1294 | $0.1196 | $0.1294 | $0.13 | $0.1196 | 2,864 | 07-04-2022 |
$0.1294 | $0.1196 | $0.1294 | $0.13 | $0.1196 | 2,864 | 07-01-2022 |
$0.11 | $0.1002 | $0.11 | $0.1133 | $0.1002 | 2,637 | 06-30-2022 |
$0.12 | $0.1002 | $0.12 | $0.12 | $0.1002 | 508 | 06-28-2022 |
$0.12 | $0.11945 | $0.12 | $0.12 | $0.1195 | 1,106 | 06-27-2022 |
News, Short Squeeze, Breakout and More Instantly...
Bison Capital Acquisition Corp. Warrant Company Name:
BCACW Stock Symbol:
NASDAQ Market:
- Healthcare institutional investors and insiders commit $15 million through private investment in public equity (“PIPE”) - - Lincoln Park Capital has committed to purchase up to $50 million of common stock - - Proceeds to advance the Phase 2 deve...